NuVasive

Smith & Nephew buys Osiris and insists it has appetite for more

The UK ortho and woundcare group might yet pounce on Nuvasive.

Fireworks among the small and mid-cap device makers

Smaller medtechs saw impressive share price growth in 2018, but not quite as good as the year before.

June 14, 2018

New filler approved, but Wright can’t match Medtronic

Wright's bone filler sales are growing fast, but Medtronic still rules.

January 10, 2018

Smaller medtechs soar in ’17 but could now be too expensive

Many small groups are up thanks to takeover speculation, and this may end up being self-defeating.

October 27, 2016

Interview – Bonesupport fills the void with $37m

July 07, 2016

Value of medtech mergers down 80%

June 08, 2016

Zimmer Biomet shows some backbone with $1bn LDR buy

January 12, 2016

Big-cap medtech shares stutter

January 07, 2016

NuVasive’s $380m Magec trick

March 30, 2015

Stryker and Osiris step into the bony void

November 20, 2014

Aggressive strategy backfires for Baxano but works for its spinal rivals

Load More